Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Monoclonal antibody (MAb) E48 reacts with a 22 kD antigen exclusively expressed in squamous and transitional epithelia and their neoplastic counterparts. Radiolabelled with 99mTc, MAb E48 is capable of targeting metastatic and recurrent disease in patients with head and neck cancer. In this study, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerretsen, M., Schrijvers, A. H., van Walsum, M., Braakhuis, B. J., Quak, J. J., Meijer, C. J., Snow, G. B., van Dongen, G. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977958/
https://www.ncbi.nlm.nih.gov/pubmed/1520586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977958/
https://www.ncbi.nlm.nih.gov/pubmed/1520586

Ejemplares similares